CVS Health Corp. (NYSE:CVS) on Wednesday posted upbeat first-quarter earnings and issued strong 2026 guidance.
The health solutions company reported adjusted earnings of $2.57 per share, surpassing analyst estimates of $2.20. Sales reached $100.43 billion, up 6.2% year over year, beating the consensus of $95.09 billion.
CVS Health raised fiscal 2026 adjusted earnings guidance from $7.00-$7.20 per share to $7.30-$7.50, compared to the consensus of $7.16. The company expects 2026 sales of more than $405 billion, compared to prior guidance of at least $400 million and the Wall Street estimate of $404.87 billion.
“CVS Health continues to provide what people want most from health care: a connected, convenient, cost-effective engagement experience across our unique collection of businesses. We build trust every day in communities across the country by providing better access, affordability and …
This post was originally published here
